ACE2.v2

Effective against all variants of COVID-19

Indications

Hospitalized or non-hospitalized high-risk patients, (replace mAbs)
Prophylaxis and Post-exposure prophylaxis (e.g. Evusheld or REGEN-COV)

Wild-type sACE2 lacks efficacy

Cyrus sACE2.v2-Fc is highly potent

3 Month Dosing